EUVIMEDEUVIMED entdecken
Crossref

Evaluation of the Inhibition Potency of Nirmatrelvir against Main Protease Mutants of SARS-CoV-2 Variants

Haihai Jiang iD, Yanru Zhou, Xiaofang Zou, Xiaohui Hu, Jie Wang, Pei Zeng, Wenwen Li, Xiangyi Zeng, Jin Zhang, Jian Li

Biochemistry · 04.07.2023 · 62 (13) · 2055-2064

DOI: 10.1021/acs.biochem.3c00075 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemistry, online erschienen am 24.05.2023. Verfasst von Haihai Jiang und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Nanchang University, Nanchang 330031, China. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Key Research and Development Program of Jiangxi Province, Science Fund for Distinguished Young Scholars of Jiangxi Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2COVID-19HumansAntiviral AgentsLactamsLeucineNitrilesPeptide HydrolasesProtease Inhibitors

Substanzen

Antiviral AgentsLactamsLeucineNitrilesPeptide HydrolasesProtease Inhibitors

Autor:innen und Institutionen

  • School of Basic Medical Sciences, Nanchang University, Nanchang 330031, China.
  • College of Pharmaceutical Sciences, Gannan Medical University, Ganzhou 341000, China.
  • Shenzhen Crystalo Biopharmaceutical Co., Ltd., Shenzhen 518118, China.
  • Jiangxi Jmerry Biopharmaceutical Co., Ltd., Ganzhou 341000, China.

ORCID-Profile: Haihai Jiang

Förderung

  • Key Research and Development Program of Jiangxi Province
  • Science Fund for Distinguished Young Scholars of Jiangxi Province
  • National Natural Science Foundation of China
  • Natural Science Foundation of Jiangxi Province
  • Gannan Medical University
  • Chinese Academy of Sciences
  • Jiangxi Double Thousand Plan

Zitieren

APA

Jiang, H., Zhou, Y., Zou, X., Hu, X., Wang, J., Zeng, P., Li, W., Zeng, X., Zhang, J., & Li, J. (2023). Evaluation of the Inhibition Potency of Nirmatrelvir against Main Protease Mutants of SARS-CoV-2 Variants. Biochemistry, 62(13), 2055-2064. https://doi.org/10.1021/acs.biochem.3c00075

Vancouver

Jiang H, Zhou Y, Zou X, Hu X, Wang J, Zeng P, et al. Evaluation of the Inhibition Potency of Nirmatrelvir against Main Protease Mutants of SARS-CoV-2 Variants. Biochemistry. 2023;62(13):2055-2064. doi:10.1021/acs.biochem.3c00075

BibTeX
@article{Jiang2023,
  author = {Jiang, Haihai and Zhou, Yanru and Zou, Xiaofang and Hu, Xiaohui and Wang, Jie and Zeng, Pei and Li, Wenwen and Zeng, Xiangyi and Zhang, Jin and Li, Jian},
  title = {Evaluation of the Inhibition Potency of Nirmatrelvir against Main Protease Mutants of SARS-CoV-2 Variants},
  journal = {Biochemistry},
  year = {2023},
  volume = {62},
  number = {13},
  pages = {2055--2064},
  doi = {10.1021/acs.biochem.3c00075}
}
Kostenlos starten →